Mark G. Schweitzer, PhD

Dr. Schweitzer is the Global Head, Analytical Science & Technology, Novartis Quality. In this role, he is responsible for the development and implementation of strategic initiatives in pharmaceutical analytical chemistry, technology development, and analytical process improvements across Novartis. During his career spanning over 35 years, Dr. Schweitzer has led analytical and formulation development groups for several major pharmaceutical companies (Abbott/AbbVie, Searle/Pharmacia/Pfizer) and private research organizations supporting pharmaceutical and agricultural product development. He has successfully delivered analytical support across the range of development programs, from early stage/FIH to technology transfer to manufacturing. Dr. Schweitzer received his Ph.D. in Chemistry from The Ohio State University in 1984. He is active in several external organizations including PhRMA, ICH, and USP. He served as the Vice Chair and Chair of the Analytical Technical Group within PhRMA; served as the rapporteur for ICH Q3D: Elemental Impurities Expert Working Group through step 2b; is currently the PhRMA topic lead for the ICH Q3D(R1) Expert Working Group; and served as the Vice Chair of the USP Chemical Analysis Expert Committee from 2017 to 2018.